4-Hydroxytolbutamide-d9(Synonyms: Hydroxytolbutamide-d9)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
4-Hydroxytolbutamide-d9 (Synonyms: Hydroxytolbutamide-d9)

4-Hydroxytolbutamide-d9 (Hydroxytolbutamide-d9) 是 4-Hydroxytolbutamide 的氘代物。4-Hydroxytolbutamide (Hydroxytolbutamide) 是 Tolbutamide 的代谢产物。4-Hydroxytolbutamide 被在体内 CYP2C8 和 CYP2C9 代谢。Tolbutamide 是第一代钾通道阻滞剂，是一种磺酰脲类口服降糖药。

4-Hydroxytolbutamide-d9(Synonyms: Hydroxytolbutamide-d9)

4-Hydroxytolbutamide-d9 Chemical Structure

CAS No. : 1185112-19-9

规格 是否有货
1 mg Check price and availability
10 mg Check price and availability

* Please select Quantity before adding items.

生物活性

4-Hydroxytolbutamide-d9 (Hydroxytolbutamide-d9) is the deuterium labeled 4-Hydroxytolbutamide. 4-Hydroxytolbutamide (Hydroxytolbutamide) is a metabolite of Tolbutamide. 4-Hydroxytolbutamide is metabolized by CYP2C8 and CYP2C9. Tolbutamide is a first generation potassium channel blocker and a sulfonylurea oral antidiabetic[1][2].

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

295.40

Formula

C12H9D9N2O4S
CAS 号

1185112-19-9
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Hansen LL, et al. Quantitative determination of tolbutamide and its metabolites in human plasma and urine by high-performance liquid chromatography and UV detection. Ther Drug Monit. 1999 Dec;21(6):664-71.

    [3]. Yuan R, et al. Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab Dispos. 2002 Dec;30(12):1311-9.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务